Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520. (Q46892005)
Jump to navigation
Jump to search
scientific article published in January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520. |
scientific article published in January 2006 |
Statements
1 reference
Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520. (English)
1 reference
Alexa Bieler
1 reference
Klaus Mantwill
1 reference
Tanja Dravits
1 reference
Alexandra Bernshausen
1 reference
Gabriel Glockzin
1 reference
Nadia Köhler-Vargas
1 reference
Hermann Lage
1 reference
Bernd Gansbacher
1 reference
Per S Holm
1 reference
1 January 2006
1 reference
1 reference
17
1 reference
1
1 reference
55-70
1 reference
Identifiers
1 reference
1 reference